# OraSure to Launch OraQuick™ HIV Self-Test in Canada
Canonical URL: https://biopharmsignal.com/news/OSUR/orasure-to-launch-oraquicktm-hiv-self-test-in-canada
Ticker: OSUR
Company: OraSure Technologies, Inc.
Source: OraSure Technologies, Inc.
Published: 2026-02-10 13:05 EST
Original Source URL: https://orasure.gcs-web.com
## Summary

BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a license from Health Canada for use in Canada.

## Article Body
BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a license from Health Canada for use in Canada.
## Recent Company News
- 2026-05-06 20:05 EST — [OraSure Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-first-quarter-2026-financial-results) — Source: OraSure Technologies, Inc.
- 2026-04-22 20:10 EST — [OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th](https://biopharmsignal.com/news/OSUR/orasure-to-announce-first-quarter-2026-financial-results-and-host-earnings-call-on-may-6th) — Source: OraSure Technologies, Inc.
- 2026-04-17 00:10 EST — [OraSure Technologies Appoints John D. Bertrand to its Board of Directors](https://biopharmsignal.com/news/OSUR/orasure-technologies-appoints-john-d-bertrand-to-its-board-of-directors) — Source: OraSure Technologies, Inc.
- 2026-03-17 20:53 EST — [OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital](https://biopharmsignal.com/news/OSUR/orasure-highlights-significant-operational-progress-and-value-creation-initiatives-following-letter-from-altai-capital) — Source: OraSure Technologies, Inc.
- 2026-02-25 21:05 EST — [OraSure Announces Fourth Quarter 2025 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-fourth-quarter-2025-financial-results) — Source: OraSure Technologies, Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)